Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study.
Tomic D, Morton JI, Chen L, Salim A, Gregg EW, Pavkov ME, Arffman M, Balicer R, Baviera M, Boersma-van Dam E, Brinks R, Carstensen B, Chan JCN, Cheng YJ, Fosse-Edorh S, Fuentes S, Gardiner H, Gulseth HL, Gurevicius R, Ha KH, Hoyer A, Jermendy G, Kautzky-Willer A, Keskimäki I, Kim DJ, Kiss Z, Klimek P, Leventer-Roberts M, Lin CY, Lopez-Doriga Ruiz P, Luk AOY, Ma S, Mata-Cases M, Mauricio D, McGurnaghan S, Imamura T, Paul SK, Peeters A, Pildava S, Porath A, Robitaille C, Roncaglioni MC, Sugiyama T, Wang KL, Wild SH, Yekutiel N, Shaw JE, Magliano DJ. Tomic D, et al. Among authors: balicer r. Lancet Diabetes Endocrinol. 2022 Nov;10(11):795-803. doi: 10.1016/S2213-8587(22)00252-2. Epub 2022 Sep 29. Lancet Diabetes Endocrinol. 2022. PMID: 36183736 Free PMC article.
Which patients with Type 2 diabetes will have greater compliance to participation in the Diabetes Conversation Map™ program? A retrospective cohort study.
Srulovici E, Feldman B, Reges O, Hoshen M, Balicer RD, Rotem M, Shadmi E, Key C, Curtis B, He X, Rubin G, Strizek A, Leventer-Roberts M. Srulovici E, et al. Diabetes Res Clin Pract. 2018 Sep;143:337-347. doi: 10.1016/j.diabres.2018.07.037. Epub 2018 Aug 3. Diabetes Res Clin Pract. 2018. PMID: 30081107
Development of a risk score for predicting the benefit versus harm of extending dual antiplatelet therapy beyond 6 months following percutaneous coronary intervention for stable coronary artery disease.
Witberg G, Plakht Y, Bental T, Feldman BS, Leventer-Roberts M, Levi A, Gabay H, Balicer R, Gerber Y, Kornowski R. Witberg G, et al. Among authors: balicer r. PLoS One. 2019 Feb 14;14(2):e0209661. doi: 10.1371/journal.pone.0209661. eCollection 2019. PLoS One. 2019. PMID: 30763340 Free PMC article.
267 results